Form 4: Bionano Genomics Executive Reports Stock Withholding for Tax Obligations

Sentiment:

SEC Form 4 Filing


Mark Oldakowski, Chief Operating Officer of Bionano Genomics, reports the withholding of 1,229 shares of common stock to cover tax obligations related to a vested RSU award.

Summary

  • On February 15, 2024, Bionano Genomics withheld 1,229 shares of common stock from Mark Oldakowski, the Chief Operating Officer, to satisfy tax obligations related to the vesting of an RSU award granted on February 15, 2023.
  • Following this transaction, Oldakowski beneficially owns 48,644 shares of Bionano Genomics common stock.
  • This includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.
  • The reporting person's ownership of 268,058 less shares of common stock due to a 1-for-10 stock split on August 4, 2023.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and does not indicate a positive or negative sentiment.

Industry Context

This is a standard SEC filing related to executive compensation and stock ownership, common for publicly traded companies.

Key Dates

DateDescription
February 15, 2023Date of RSU award grant
June 12, 2023Date of acquisition of shares under the Employee Stock Purchase Plan
August 4, 2023Date of 1-for-10 stock split
February 15, 2024Date of stock withholding for tax obligations
March 05, 2024Date of Form 4 filing

Keywords

Bionano Genomics, BNGO, Form 4, Stock Withholding, RSU, Mark Oldakowski, Chief Operating Officer, Beneficial Ownership, Employee Stock Purchase Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.